Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.
Department of Neurology, Friedrich-Alexander University Erlangen (FAU), Erlangen, Germany.
Clin Neurol Neurosurg. 2024 Aug;243:108381. doi: 10.1016/j.clineuro.2024.108381. Epub 2024 Jun 10.
Cervical artery dissection (CAD) is a relevant etiology of transient ischemic attacks and strokes. Several trials explored the significance of specific antithrombotic treatments, i.e. oral anticoagulation (OAC) versus antiplatelet treatment (APT), on recurrent ischemic complications and clinical outcomes. As overall incidence rates of complications were low there is still controversy which antithrombotic treatment should be used. However, up to now there has been no systematic investigation among CAD-patients with ischemic stroke specifically comparing clinical course and outcome of patients with anterior versus posterior CAD.
We performed an individual participant data analysis of patients with CAD and ischemic stroke. Over a five-year period we pooled data from three sites (i.e. West China Hospital, Chengdu, China as well as Erlangen and Giessen University Hospitals, Germany) and enrolled patients with CAD-associated ischemic stroke. Patient demographics, clinical and in-hospital measures as well as radiological data were retrieved from institutional databases. Clinical follow-up was over 6 months and included data on recurrent ischemic strokes and hemorrhages as well as clinical functional outcome assessed by the modified Rankin Scale dichotomized into favourable (mRS=0-2) and unfavourable.
A total of 203 patients with CAD were included of which n=112 had anterior and n=91 had posterior CAD. Patients with posterior CAD were younger (46.0 vs. 41.0 y; p<0.001) than patients with anterior CAD and showed less often arterial hypertension. (42.0 % vs. 28.6 %; p<0.048). Antithrombotic treatment with APT and OAC was similarily distributed among patients with anterior and posterior CAD and not significantly differently related to ischemic or hemorrhagic complications during follow-up (all p=n.s.). Main difference between Chinese and German patients were mode of antithrombotic treatment consisting predominantly of APT in China compared to OAC in Germany. Functional outcome overall was good, yet worse in patients with anterior CAD compared to posterior CAD (80.2 % favorable in anterior CAD vs. 92.2 % in posterior CAD (p=0.014).
This study provides evidence that anterior and posterior CAD show baseline imbalances regarding age and comorbidity which may affect clinical outcome. There are no signals of superiority or harm of any specific mode of antithrombotic treatment nor relevant discrepancies in clinical outcome among Chinese and German CAD-associated stroke patients.
颈内动脉夹层(CAD)是短暂性脑缺血发作和中风的一个重要病因。几项试验探讨了特定抗血栓治疗(即口服抗凝治疗[OAC]与抗血小板治疗[APT])对复发性缺血性并发症和临床结局的意义。由于总体并发症发生率较低,因此对于应使用哪种抗血栓治疗仍存在争议。然而,迄今为止,尚无针对特定缺血性中风的 CAD 患者的系统研究,比较前循环和后循环 CAD 患者的临床病程和结局。
我们对 CAD 合并缺血性中风的患者进行了个体参与者数据分析。在五年期间,我们从三个地点(中国成都的华西医院以及德国埃尔兰根和吉森大学医院)汇总数据,并招募了 CAD 相关缺血性中风的患者。从机构数据库中检索患者的人口统计学、临床和住院相关措施以及影像学数据。临床随访超过 6 个月,包括复发性缺血性中风和出血以及通过改良 Rankin 量表(mRS)进行的临床功能结局评估,mRS 分为有利(mRS=0-2)和不利(mRS=3-6)。
共纳入 203 例 CAD 患者,其中 112 例为前循环 CAD,91 例为后循环 CAD。后循环 CAD 患者年龄较小(46.0 岁 vs. 41.0 岁;p<0.001),且动脉高血压的发生率较低(42.0% vs. 28.6%;p<0.048)。前循环和后循环 CAD 患者的 APT 和 OAC 抗血栓治疗的分布相似,且与随访期间的缺血或出血并发症无显著相关性(均 p=n.s.)。中国和德国患者的主要差异在于抗血栓治疗模式,中国主要采用 APT,而德国主要采用 OAC。整体功能结局良好,但前循环 CAD 患者的结局较差,与后循环 CAD 患者相比(前循环 CAD 中 80.2%的结局有利,后循环 CAD 中 92.2%的结局有利(p=0.014)。
本研究表明,前循环和后循环 CAD 在年龄和合并症方面存在基线不平衡,这可能影响临床结局。在中国和德国的 CAD 相关中风患者中,任何特定抗血栓治疗模式均无优势或危害的迹象,且临床结局也无明显差异。